Effects on vital parameters of drugs that stimulate uterine contractions like Oxytocin and carbetocin given as a bolus in a women undergoing caesarean delivery

Hemodynamic effects of Carbetocin and Oxytocin given as an intravenous bolus in a women undergoing caesarean delivery: A randomised trail - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/064265

Enrollment

Registered

2024-03-18

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O720- Third-stage hemorrhage

Interventions

Control Intervention1: Carbetocin: Injection carbetocin 100mcg intravenously Control Intervention2: Oxytocin: Injection Oxytocin 5U intravenously

Eligibility

Inclusion criteria

Inclusion criteria: 1.Parturients who are willing to give informed written consent 2. Parturients of all age groups 3. Parturients who are ASA grade 2

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Comparison of maternal heart rateTimepoint: To assess after 1,3,5,7,10 minutes after administration of the drugs	—

Secondary

Measure	Time frame
Comparison of other hemodynamic parameters like SBP, DBP and MAPTimepoint: To assess after 1,3,5,7,10 minutes after administration of the drugs	—

Countries

India

Contacts

Public ContactDr Tulsi T

Bangalore medical college and research institute

drtulsikeshav1@gmail.com9483188870

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026